Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Varga, G.
Right arrow Articles by Szamel, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varga, G.
Right arrow Articles by Szamel, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 11, No. 11, 1851-1862, November 1999
© 1999 Japanese Society for Immunology

Molecular mechanisms of T lymphocyte activation: convergence of T cell antigen receptor and IL-1 receptor-induced signaling at the level of IL-2 gene transcription

Georg Varga, Ursula Dreikhausen, Michael Kracht, Annette Appel, Klaus Resch and Marta Szamel

Institute of Molecular Pharmacology, Medical School Hannover, Carl-Neuberg Strasse 1, 30625 Hannover, Germany

Correspondence to: M. Szamel

Co-stimulation of murine EL-4 thymoma cells—carrying high numbers of TCR and type I IL-1 receptors (IL-1R)—with anti-CD3 antibodies and IL-1 resulted in synergistic enhancement of IL-2 synthesis. While the extracellular signal-regulated kinase (ERK) cascade was activated by both receptors, IL-1 preferentially stimulated Jun-N-terminal kinases (JNK) and p38 mitogen-activated kinase or microtubule-associated protein kinase (MAPK). Interruption of TCR- or IL-1R-stimulated ERK cascade by PD-98059, a specific inhibitor of MAP/ERK kinase (MEK), resulted in partial suppression of nuclear factor of activated T cells activation and in complete inhibition of IL-1-stimulated NF{kappa}B activation. Suppression of activation of both MEK and p38 MAPK resulted in significant inhibition of IL-2 gene expression. The results show that maximal activation of the IL-2 gene requires activation of at least two different protein kinase cascades, i.e. of the ERK and p38 pathways but presumably also that of JNK which converge at the level of the IL-2 promoter resulting in enhancement of its transcriptional activity.

Keywords: IL-2, protein kinases, signal transduction, T lymphocytes

Transmitting editor: M. Reth


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. L. Kang, H. S. Lee, H. J. Jung, H. J. Kim, J. S. Hah, and V. Castranova
Inhibition of Mitogenic Stimulant-Induced Activation of Thymocytes with Zinc Tetrakis-(N-Methyl-4'-Pyridyl) Porphyrinato
J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1138 - 1144.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Bostik, P. Wu, G. L. Dodd, F. Villinger, A. E. Mayne, V. Bostik, B. D. Grimm, D. Robinson, H.-J. Kung, and A. A. Ansari
Identification of Protein Kinases Dysregulated in CD4+ T Cells in Pathogenic versus Apathogenic Simian Immunodeficiency Virus Infection
J. Virol., December 1, 2001; 75(23): 11298 - 11306.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
P. Bostik, A. E. Mayne, F. Villinger, K. P. Greenberg, J. D. Powell, and A. A. Ansari
Relative Resistance in the Development of T Cell Anergy in CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys
J. Immunol., January 1, 2001; 166(1): 506 - 516.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.